EUVIMEDEUVIMED entdecken
Multizentrische StudieValidierungsstudieOpen Access · CC BY-NC 3.0

Validating the Korean Geriatric Assessment Tool in Elderly Multiple Myeloma Patients: A Multicenter Study

Ji Yun Lee, Sang-A Kim, Youngil Koh, Ho-Young Yhim, Gyeong-Won Lee, Chang-Ki Min, Young Rok Do, Hyo Jung Kim, Sung Hwa Bae, Hyeon-Seok Eom, Sung-Hoon Jung, Hyunkyung Park und 6 weitere

Cancer Research and Treatment · 2026

DOI: 10.4143/crt.2025.066 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Cancer Research and Treatment, 2026. Verfasst von Ji Yun Lee und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology-Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Me…. Hauptthemen laut MEDLINE: Multiple Myeloma, Geriatric Assessment, Frailty. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Seoul National University Bundang Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study evaluates the Korean Cancer Study Group Geriatric Score-7 (KG-7) frailty screening tool’s effectiveness in elderly multiple myeloma (MM) patients to prevent under and overtreatment.Materials and Methods This prospective pilot cohort study included 100 elderly patients aged 70 and older with newly diagnosed MM who had not undergone transplantation from August 2020 to January 2022.

Results

The median age was 77 years, and 73.0% of patients were classified at International Staging System stages 2 or 3. Using a 5-point cutoff on the KG-7 index (non-frail, score ≥ 5; frail, score < 5), 31% were categorized as frail. After a median follow-up of 26.8 months, the 3-year overall survival rate was 73.0%. There was no statistically significant association between any frailty index and the risk of death. However, frail patients defined by the simplified frailty index (hazard ratio [HR], 2.49; 95% confidence interval [CI], 1.09 to 5.95; p=0.030) and by KG-7 (HR, 2.43; 95% CI, 1.03 to 5.86; p=0.043) had a significantly higher risk of grade 3-4 non-hematologic toxicity, whereas the International Myeloma Working Group definition did not. Over a 24-month tracking period, vulnerability as measured by KG-7 either improved or deteriorated.

Conclusion

The pilot study, which had a limited number of participants, did not demonstrate KG-7’s effectiveness in predicting survival; however, it successfully predicted severe non-hematologic toxicities. We plan to conduct larger studies in elderly MM patients to determine whether KG-7 can help tailor their treatment regimens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaGeriatric AssessmentFrailtyHumansAgedMaleFemaleRepublic of KoreaAged, 80 and overPilot ProjectsProspective StudiesFrail Elderly

Stichwörter der Autor:innen

AgedFrailtyMultiple myelomaSurvivalToxicity

Autor:innen und Institutionen

  • Division of Hematology-Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
  • Division of Hematology-Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
  • Division of Hematology-Oncology, Department of Internal Medicine, Jeonbuk National University Hospital, Jeonbuk National University College of Medicine, Jeonju, Korea.
  • Division of Hematology-Oncology, Department of Internal Medicine, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Korea.
  • Division of Hematology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Division of Hematology-Oncology, Department of Internal Medicine, Dongsan Medical Center, Keimyung University School of Medicine, Daegu, Korea.

Förderung

  • Seoul National University Bundang Hospital

Zitieren

APA

Lee, J. Y., Kim, S. A., Koh, Y., Yhim, H. Y., Lee, G. W., Min, C. K., Do, Y. R., Kim, H. J., Bae, S. H., Eom, H. S., Jung, S. H., Park, H., Nam, S. H., Lee, J. H., Kim, S. H., Lee, H. J., Park, Y. S., & Bang, S. M. (2026). Validating the Korean Geriatric Assessment Tool in Elderly Multiple Myeloma Patients: A Multicenter Study. Cancer Research and Treatment. https://doi.org/10.4143/crt.2025.066

Vancouver

Lee JY, Kim SA, Koh Y, Yhim HY, Lee GW, Min CK, et al. Validating the Korean Geriatric Assessment Tool in Elderly Multiple Myeloma Patients: A Multicenter Study. Cancer Research and Treatment. 2026. doi:10.4143/crt.2025.066

BibTeX
@article{Lee2026,
  author = {Lee, Ji Yun and Kim, Sang-A and Koh, Youngil and Yhim, Ho-Young and Lee, Gyeong-Won and Min, Chang-Ki and Do, Young Rok and Kim, Hyo Jung and Bae, Sung Hwa and Eom, Hyeon-Seok and Jung, Sung-Hoon and Park, Hyunkyung and Nam, Seung-Hyun and Lee, Ji Hyun and Kim, Sung-Hyun and Lee, Hyun Jung and Park, Young Seob and Bang, Soo-Mee},
  title = {Validating the Korean Geriatric Assessment Tool in Elderly Multiple Myeloma Patients: A Multicenter Study},
  journal = {Cancer Research and Treatment},
  year = {2026},
  doi = {10.4143/crt.2025.066}
}
Kostenlos starten →